EA010428B1 - Инактивация патогена в препарате путем обработки формалином и уф светом - Google Patents

Инактивация патогена в препарате путем обработки формалином и уф светом Download PDF

Info

Publication number
EA010428B1
EA010428B1 EA200602206A EA200602206A EA010428B1 EA 010428 B1 EA010428 B1 EA 010428B1 EA 200602206 A EA200602206 A EA 200602206A EA 200602206 A EA200602206 A EA 200602206A EA 010428 B1 EA010428 B1 EA 010428B1
Authority
EA
Eurasian Patent Office
Prior art keywords
formalin
virus
preparation
inactivation
light
Prior art date
Application number
EA200602206A
Other languages
English (en)
Russian (ru)
Other versions
EA200602206A1 (ru
Inventor
Манфред Райтер
Вольфганг Мундт
Ноэль Барретт
Отфрид Кистнер
Original Assignee
Бакстер Интернэшнл Инк.
Бакстер Хелткэр С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бакстер Интернэшнл Инк., Бакстер Хелткэр С.А. filed Critical Бакстер Интернэшнл Инк.
Publication of EA200602206A1 publication Critical patent/EA200602206A1/ru
Publication of EA010428B1 publication Critical patent/EA010428B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M31/00—Means for providing, directing, scattering or concentrating light
    • C12M31/02—Means for providing, directing, scattering or concentrating light located outside the reactor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • A61L2103/05—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/11—Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA200602206A 2004-05-27 2005-05-26 Инактивация патогена в препарате путем обработки формалином и уф светом EA010428B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57531004P 2004-05-27 2004-05-27
PCT/EP2005/005691 WO2005118000A1 (en) 2004-05-27 2005-05-26 Inactivation of a pathogen in a sample by a treatment with formalin and uv light

Publications (2)

Publication Number Publication Date
EA200602206A1 EA200602206A1 (ru) 2007-04-27
EA010428B1 true EA010428B1 (ru) 2008-08-29

Family

ID=34968615

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200602206A EA010428B1 (ru) 2004-05-27 2005-05-26 Инактивация патогена в препарате путем обработки формалином и уф светом

Country Status (17)

Country Link
EP (1) EP1753470B1 (enExample)
JP (2) JP5502276B2 (enExample)
KR (1) KR101483337B1 (enExample)
CN (1) CN1956739B (enExample)
AU (1) AU2005249204B2 (enExample)
BR (1) BRPI0511467A (enExample)
CA (1) CA2567336C (enExample)
CR (1) CR8805A (enExample)
EA (1) EA010428B1 (enExample)
EC (1) ECSP067118A (enExample)
ES (1) ES2553457T3 (enExample)
IL (1) IL179262A (enExample)
MX (1) MXPA06013633A (enExample)
NO (1) NO20065912L (enExample)
NZ (1) NZ551857A (enExample)
WO (1) WO2005118000A1 (enExample)
ZA (1) ZA200610490B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06013633A (es) * 2004-05-27 2007-03-23 Baxter Int Inactivacion de un patogeno en una muestra a traves de un tratamiento con formalina y luz ultravioleta.
GB0706507D0 (en) * 2007-04-03 2007-05-09 Medi Immune Ltd Protective device
EP2173861B2 (en) 2007-06-15 2017-02-22 Amgen Inc. Methods of treating cell culture media for use in a bioreactor
JP6200805B2 (ja) * 2010-05-03 2017-09-20 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規な方法
JP5968795B2 (ja) * 2013-01-10 2016-08-10 四国化工機株式会社 紫外線殺菌装置
CN103992936B (zh) * 2014-04-22 2015-10-07 北京科兴生物制品有限公司 一种封闭式甲醛灭活病毒管道系统及其应用
WO2020023942A2 (en) 2018-07-27 2020-01-30 Terumo Bct Biotechnologies, Llc Fluid flow-through
CN111840596B (zh) * 2020-06-11 2022-03-11 南岳生物制药有限公司 核黄素光化学血浆灭活装置及其控制系统、控制方法
EP4190366A4 (en) 2020-07-27 2024-11-20 Riken INFECTION PREVENTION DEVICE AND INFECTION PREVENTION METHOD
US12447225B2 (en) 2021-06-25 2025-10-21 University Of South Florida Ultrafast-UV laser integrating cavity mediated inactivation of a pathogen
CN114229953B (zh) * 2021-12-25 2022-11-18 无锡诚源环境科技有限公司 腔体式紫外消毒器的紫外线剂量计算方法
GB2631765A (en) * 2023-07-13 2025-01-15 Univ Cranfield Viral inactivation reactor and method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB802048A (en) * 1955-08-26 1958-09-24 Parke Davis & Co Vaccine products and method for producing the same
US3926556A (en) * 1973-05-30 1975-12-16 Raymond Marcel Gut Boucher Biocidal electromagnetic synergistic process
US5247178A (en) * 1991-12-12 1993-09-21 Fusion Systems Corporation Method and apparatus for treating fluids by focusing reflected light on a thin fluid layer
SU1367487A1 (ru) * 1986-01-29 1995-10-27 Институт полиомиелита и вирусных энцефалитов АМН СССР Способ получения антирабической вакцины
US20020096648A1 (en) * 2000-11-13 2002-07-25 Klaus Kaiser Apparatus for irradiating liquids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
MXPA06013633A (es) * 2004-05-27 2007-03-23 Baxter Int Inactivacion de un patogeno en una muestra a traves de un tratamiento con formalina y luz ultravioleta.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB802048A (en) * 1955-08-26 1958-09-24 Parke Davis & Co Vaccine products and method for producing the same
US3926556A (en) * 1973-05-30 1975-12-16 Raymond Marcel Gut Boucher Biocidal electromagnetic synergistic process
SU1367487A1 (ru) * 1986-01-29 1995-10-27 Институт полиомиелита и вирусных энцефалитов АМН СССР Способ получения антирабической вакцины
US5247178A (en) * 1991-12-12 1993-09-21 Fusion Systems Corporation Method and apparatus for treating fluids by focusing reflected light on a thin fluid layer
US20020096648A1 (en) * 2000-11-13 2002-07-25 Klaus Kaiser Apparatus for irradiating liquids

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DARNELL M.E.R. ET AL.: "Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV" JOURNAL OF VIROLOGICAL METHODS, AMSTERDAM, NL, vol. 121, no. 1, October 2004 (2004-10), pages 85-91, XP004551409 ISSN: 0166-0934 paragraphs '02.3!, '02.6!, '03.1!, '03.3! *
DATABASE WPI Section Ch, Week 199627 Derwent Publications Ltd., London, GB; Class A96, AN 1996-266694 XP002337093 & SU 1367487 A1 (A MED POLYMIELITIS VIRAL ENCEPHELITIS) 27 October 1995 (1995-10-27) abstract *

Also Published As

Publication number Publication date
CA2567336A1 (en) 2005-12-15
CN1956739A (zh) 2007-05-02
EP1753470A1 (en) 2007-02-21
AU2005249204B2 (en) 2010-07-15
IL179262A0 (en) 2007-03-08
HK1105374A1 (zh) 2008-02-15
NO20065912L (no) 2007-02-26
ECSP067118A (enExample) 2007-02-28
EP1753470B1 (en) 2015-08-19
WO2005118000A1 (en) 2005-12-15
EA200602206A1 (ru) 2007-04-27
ES2553457T3 (es) 2015-12-09
JP5675690B2 (ja) 2015-02-25
IL179262A (en) 2011-01-31
CR8805A (es) 2007-06-19
JP2012143249A (ja) 2012-08-02
AU2005249204A1 (en) 2005-12-15
ZA200610490B (en) 2008-10-29
KR101483337B1 (ko) 2015-01-15
CA2567336C (en) 2010-11-23
MXPA06013633A (es) 2007-03-23
KR20110099810A (ko) 2011-09-08
BRPI0511467A (pt) 2007-12-26
JP5502276B2 (ja) 2014-05-28
CN1956739B (zh) 2011-12-28
JP2008500303A (ja) 2008-01-10
NZ551857A (en) 2009-11-27

Similar Documents

Publication Publication Date Title
JP5675690B2 (ja) ホルマリンおよびｕｖ光での処理によるサンプル中の病原体の不活化
Darnell et al. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
ES2270501T3 (es) Procedimiento para la inactivacion de virus envueltos.
US4693981A (en) Preparation of inactivated viral vaccines
AU764592B2 (en) Methods and compositions for the selective modification of nucleic acids
KR101760844B1 (ko) 바이러스성 백신의 제조 방법
US8703467B2 (en) Inactivation of a pathogen in a sample by a treatment with formalin and UV light
RU2466742C2 (ru) Способ инактивирования патогенов в донорской крови, плазме крови или концентратах эритроцитов в гибких контейнерах с помощью встряхивания
Gracheva et al. Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light
Vaidya et al. Ultraviolet-C irradiation for inactivation of viruses in foetal bovine serum
US6165711A (en) Process for disintegrating nucleic acids and preparing biological products of guaranteed quality
JPS61158783A (ja) ヒトの腫瘍白血病ウイルス３のソラレンによる不活化
Wiktor et al. Immunogenicity of rabies virus inactivated by β-propiolactone, acetylethyleneimine, and ionizing irradiation
JP2021519782A (ja) 照射によって不活化されたポリオウイルス、それを含む組成物、および調製方法
KR20070030852A (ko) 포르말린 및 ｕｖ광으로의 처리에 의한 샘플 중 병원균의불활성화
CA2716426A1 (en) Inactivation of a pathogen in a sample by a treatment with formalin and uv light
HK1105374B (en) A method for inactivating a virus contained in a sample
US20250177534A1 (en) Thermostable uv inactivated vaccines and other biopharmaceuticals
Eftekhari et al. Evaluation of the effects of concentration, duration and temperature of incubation with Beta-Propiolactone on inactivation of cell-derived rabies virus
JP2009005589A (ja) Ｕｖによるｃ型肝炎ウイルスの不活化方法
SU903380A1 (ru) Ингибитор вирусов
Mirshafiee et al. Induction of nucleic acid damage in viral genomes using riboflavin in combination with UV Light
Mayerhofer et al. UV irradiation for the manufacturing of viral vaccines: state-of-the-art and perspectives in modern vaccine processing
Mirshafiee et al. Induction of Nucleic Acid Damage in Viral Genomes using Riboflavin in Combination with UV Light

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU